Abstract
Therapy regimens for Chronic lymphocytic leukemia (CLL) commonly include chemotherapy and immunotherapy, which act through complement-mediated-cytotoxicity (CDC) and other mechanisms. CDC depends on several factors, including the availability and activity of the complement classical pathway (CP). Recently, a significant decrease in CP activity was shown to be associated with an immunoglobulin-C5a complex (Ig-C5a) and other markers of chronic CP activation in 40% of the patients. The study focused on the involvement of IgG-hexamers, an established CP activator, in the mechanism of chronic CP activation in CLL. Sera from 51 naïve CLL patients and 20 normal controls were collected. CP and alternative pathway (AP) activities were followed by the complement activity marker sC5b-9. Serum high molecular weight (HMW) proteins were collected by gel-filtration chromatography and their complement activation capacity was assessed. The levels of IgM, another established CP activator, were measured. Data were associated with the presence of Ig-C5a. Baseline levels of activation markers negatively correlated with CP and the AP activities, supporting chronic complement activation. In patients with Ig-C5a, HMW proteins that are not IgM, activat...Continue Reading
References
Sep 1, 1979·Molecular Immunology·N C Hughes-Jones, B Gardner
Jan 1, 1988·Complement·L VargaS R Hollán
Jan 1, 1995·Clinical and Experimental Immunology·L VargaG Füst
Jul 11, 1998·Immunology·S RedpathM R Clark
May 20, 2005·The Journal of Clinical Investigation·Maxime HervéEric Meffre
Jun 16, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Regina MichelisBatya Kristal
Jul 7, 2010·Nature Reviews. Clinical Oncology·Constantine S Tam, Michael J Keating
Jul 9, 2010·Blood·Samantha M JaglowskiJohn C Byrd
Oct 30, 2010·Clinical Lymphoma, Myeloma & Leukemia·Susan O'Brien, Anders Osterborg
Jan 19, 2011·Haematologica·Kate HodgsonCarol Moreno
Mar 1, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Frank J BeurskensRonald P Taylor
Jun 29, 2012·Leukemia & Lymphoma·Jane A FreemanStephen P Mulligan
Mar 15, 2014·Science·Christoph A DiebolderPaul W H I Parren
May 3, 2014·Leukemia·O MiddletonH Wheadon
Jun 1, 1986·Immunology Today·A FeinsteinM I Taussig
Nov 5, 2014·Frontiers in Immunology·Gestur VidarssonTheo Rispens
Feb 24, 2015·Molecular Immunology·Joost P M MelisPaul W H I Parren
Apr 26, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sofia MortensenGregers R Andersen
May 2, 2015·Cancer·Sameer A ParikhTait D Shanafelt
Jan 7, 2016·PLoS Biology·Rob N de JongPaul W H I Parren
Dec 23, 2016·Advances in Therapy·Kensei TobinaiGünter Fingerle-Rowson
Jan 20, 2017·Nature Reviews. Disease Primers·Thomas J KippsKanti Rai
Mar 16, 2017·Leukemia Research·Francesca R MauroMassimo Gentile
Mar 25, 2018·Blood Reviews·Talal HilalJose F Leis
Jan 3, 2019·PloS One·Regina MichelisAndrei Braester
Aug 1, 2019·American Journal of Hematology·Michael Hallek